| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
124,050,000 |
| Market
Cap: |
308.88(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.21 - $4.52 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8.2 |
| Insider 6 Months : 8.2 |
| Insider 3/6 Months : 16.8 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ARYA Sciences Acquisition Corp III is a newly organized blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Co.'s primary focus is on the healthcare or healthcare related industries targeting North American or European companies in the life sciences and medical technology sectors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
50,000 |
50,000 |
50,000 |
303,000 |
| Total Buy Value |
$140,533 |
$140,533 |
$140,533 |
$822,761 |
| Total People Bought |
1 |
1 |
1 |
5 |
| Total Buy Transactions |
5 |
5 |
5 |
17 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Altman Michael Seth |
|
• • – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
I/I |
4,146,500 |
499,000 |
|
- |
|
| Altman Michael Seth |
|
• • – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
I/I |
499,000 |
0 |
|
- |
|
| Edelman Joseph |
Former Director |
– – – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,914,113 |
8,911,151 |
|
- |
|
| Edelman Joseph |
Former Director |
– – – |
2021-06-09 |
4 |
B |
$10.00 |
$55,000,000 |
I/I |
5,500,000 |
5,997,038 |
0.01 |
-49% |
|
| Mallick Parag |
Chief ScientistOfficer |
• • • |
2021-06-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,689,892 |
|
-49% |
|
| Murphy Matthew B. |
General CounselOfficer |
• – – |
2021-06-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
29,140 |
|
-49% |
|
| Mcilwain Matthew S |
Director |
– • – |
2021-06-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,020,770 |
|
-49% |
|
| Mcilwain Matthew S |
Director |
– • – |
2021-06-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
322,105 |
|
-49% |
|
| Nazem Farzad |
Director |
– • – |
2021-06-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,888,146 |
|
-49% |
|
| Horowitz Benjamin A |
10% Owner |
– – • |
2021-06-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,653,917 |
|
-49% |
|
| Patel Sujal M |
CEO, President, and SecretaryO |
• • • |
2021-06-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,094,511 |
|
-49% |
|
| Patel Sujal M |
CEO, President, and SecretaryO |
• • • |
2021-06-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,614,388 |
|
-49% |
|
| Pande Vijay Satyanand |
Director |
– • – |
2021-06-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,653,917 |
|
-49% |
|
| Posard Matthew L. |
Director |
– • – |
2021-06-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
100,000 |
|
-49% |
|
| Edelman Joseph |
Director |
– • – |
2021-06-03 |
4 |
B |
$10.05 |
$3,317,003 |
I/I |
330,050 |
489,975 |
2.1 |
-46% |
|
| Edelman Joseph |
Former Director |
– – – |
2021-05-24 |
4 |
B |
$10.05 |
$70,983 |
D/D |
7,063 |
497,038 |
2.44 |
-40% |
|
| Edelman Joseph |
Director |
– • – |
2021-05-20 |
4 |
B |
$10.05 |
$1,607,246 |
I/I |
159,925 |
159,925 |
2.1 |
-39% |
|
| Arya Sciences Holdings Iii |
|
• • • |
2020-08-11 |
4 |
A |
$10.00 |
$4,990,000 |
D/D |
499,000 |
499,000 |
|
- |
|
| Altman Michael Seth |
Chief Financial Officer |
• • • |
2020-08-11 |
4 |
A |
$10.00 |
$4,990,000 |
I/I |
499,000 |
499,000 |
|
- |
|
| Stone Adam Leo |
Chief Executive Officer |
• • • |
2020-08-11 |
4 |
A |
$10.00 |
$4,990,000 |
I/I |
499,000 |
499,000 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.07 (2.89%) 
